nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute microvascular effects of anti-angiogenic treatment in a rat model of human breast cancer using macromolecular contrast-enhanced magnetic resonance imaging
|
Fournier, Laure S. |
|
2005 |
12 |
5S |
p. S82-S83 2 p. |
artikel |
2 |
All-in-one imaging protocols for potential living liver donors: comparison of MRT and Multislice-CT with intraoperative findings
|
Ruehm, Stefan G. |
|
2005 |
12 |
5S |
p. S61- 1 p. |
artikel |
3 |
An Inexpensive Vascularized Tumor Model for Vascular Imaging
|
Wu, Max |
|
2005 |
12 |
5S |
p. S41-S42 2 p. |
artikel |
4 |
A Novel Double-Contrast Technique to Facilitate MRI-Guided Vascular Interventions: Combined Use of a Blood-Pool Agent and Carbon Dioxide
|
Maes, Robbert M. |
|
2005 |
12 |
5S |
p. S62-S63 2 p. |
artikel |
5 |
A Receptor-Binding Optical Agent for In Vivo Measurement of Receptor Biochemistry
|
Vera, David |
|
2005 |
12 |
5S |
p. S74-S75 2 p. |
artikel |
6 |
Assessment of Brain Perfusion in Stroke Patients with Echo Contrast Enhanced Transcranial Ultrasound: Preliminary Results
|
Hoelscher, Thilo |
|
2005 |
12 |
5S |
p. S65-S66 2 p. |
artikel |
7 |
Assessment of microvascular perfusion changes in a rat breast tumor model using SonoVue™ to monitor the effects of different anti-angiogenic therapies
|
Broillet, A. |
|
2005 |
12 |
5S |
p. S28-S33 6 p. |
artikel |
8 |
Assessment of Therapy in Hypertrophied Hearts Using Contrast Enhanced MRI
|
Saeed, Maythem |
|
2005 |
12 |
5S |
p. S60- 1 p. |
artikel |
9 |
Characterisation and Design of Microbubble Ultrasound Contrast Agents
|
Stride, Eleanor |
|
2005 |
12 |
5S |
p. S67-S68 2 p. |
artikel |
10 |
Comparative Clinical Pharmacokinetic Studies with Levovist and SonoVue
|
Lim, Adrian |
|
2005 |
12 |
5S |
p. S64-S65 2 p. |
artikel |
11 |
Comparison of Macromolecular Contrast Agents for Dynamic Micromagnetic Resonance Lymphangiography
|
Kobayashi, Hisataka |
|
2005 |
12 |
5S |
p. S51-S52 2 p. |
artikel |
12 |
Contrast ultrasound for sentinel node localization in head and neck cancer
|
Wisner, Erik R. |
|
2005 |
12 |
5S |
p. S49-S50 2 p. |
artikel |
13 |
Cover 1
|
|
|
2005 |
12 |
5S |
p. CO1- 1 p. |
artikel |
14 |
Detection Of Liver Metastases From Gastrointestinal Cancer: Comparision Of High Resolution MnDPDP Enhanced MRI And FDG-PET
|
Kalva, Sanjeeva P. |
|
2005 |
12 |
5S |
p. S17-S20 4 p. |
artikel |
15 |
Development of Superparamagnetic Particles Dispersions Basic Materials of Markers for Molecular Imaging
|
Muller, R.N. |
|
2005 |
12 |
5S |
p. S45- 1 p. |
artikel |
16 |
Distribution Kinetics of Polymeric MR Contrast Agent in Tumor
|
Okumura, Masafumi |
|
2005 |
12 |
5S |
p. S81- 1 p. |
artikel |
17 |
Distribution List Name: 1-CMR Attendees Members and e-mail addresses:
|
|
|
2005 |
12 |
5S |
p. S1- 1 p. |
artikel |
18 |
Drug Delivery by Angiographic Contrast Media: Inhibition of Restenosis
|
Speck, Ulrich |
|
2005 |
12 |
5S |
p. S14-S17 4 p. |
artikel |
19 |
Dynamic Interventional MR Imaging Using Hyperpolarized C-13
|
Golman, K. |
|
2005 |
12 |
5S |
p. S70-S71 2 p. |
artikel |
20 |
Editorial board
|
|
|
2005 |
12 |
5S |
p. A1- 1 p. |
artikel |
21 |
Feridex-Labeled Mesenchymal Stem Cells: Cellular Differentiation and MR Assessment in a Canine Myocardial Infarction Model
|
Bulte, Jeff W.M. |
|
2005 |
12 |
5S |
p. S2-S6 5 p. |
artikel |
22 |
Ferucarbotran-enhanced perfusion MR imaging of the liver in patients with hypervascular hepatocellular carcinomas
|
Hirohashi, Shinji |
|
2005 |
12 |
5S |
p. S45-S46 2 p. |
artikel |
23 |
Fiberoptic catheter-based near infrared imaging of protease activity and marker gene expression
|
Funovics, Martin A. |
|
2005 |
12 |
5S |
p. S76-S77 2 p. |
artikel |
24 |
Fluorinated Substances as Contrast Agents for Lung Imaging Using 19F-MRI
|
Heussel, C.P. |
|
2005 |
12 |
5S |
p. S71-S72 2 p. |
artikel |
25 |
Focal liver lesion characterization using low acoustic power ultrasound imaging
|
Quaia, Emilio |
|
2005 |
12 |
5S |
p. S66- 1 p. |
artikel |
26 |
Fold-Carrying Particles: Improvement of Targeted Microbubble Attachment
|
Klibanov, A.L. |
|
2005 |
12 |
5S |
p. S43-S44 2 p. |
artikel |
27 |
Functional and cellular imaging of acute renal failure in the mouse or rat model using gadolinium- and iron-based macromolecular MRI contrast agents
|
Kobayashi, Hisataka |
|
2005 |
12 |
5S |
p. S77-S78 2 p. |
artikel |
28 |
Gadobenate dimeglumine (MultiHance®) in MR imaging of the CNS: studies to assess the benefits of a high relaxivity contrast agent
|
Essig, Marco |
|
2005 |
12 |
5S |
p. S23-S27 5 p. |
artikel |
29 |
Gadolinium-DTPA-dextran: A molecular MR blood pool contrast agent
|
Sirlin, Claude B. |
|
2005 |
12 |
5S |
p. S80-S82 3 p. |
artikel |
30 |
Glucose Receptor Magnetic Resonance Imaging of Tumors: Experimental Study With Pegylated Paramagnetic Lipid Vesicles
|
Cuenod, Charles A. |
|
2005 |
12 |
5S |
p. S39- 1 p. |
artikel |
31 |
Immediate reactions to contrast material: first results of the French multicenter study
|
Laroche, D. |
|
2005 |
12 |
5S |
p. S53-S54 2 p. |
artikel |
32 |
Improved Paramagnetic Chelate for Molecular Imaging with MRI
|
Winter, Patrick M. |
|
2005 |
12 |
5S |
p. S40-S41 2 p. |
artikel |
33 |
Inhibition of in-Stent Restenosis of Porcine Peripheral Arteries by a Single Intraarterial Injection of Contrast Medium Mixed with Paclitaxel
|
Albrecht, Thomas |
|
2005 |
12 |
5S |
p. S48- 1 p. |
artikel |
34 |
In vivo cellular imaging of magnetically labelled hybridomas in the spleen on a 1.5 T clinical MRI system
|
Clément, O. |
|
2005 |
12 |
5S |
p. S39-S40 2 p. |
artikel |
35 |
In vivo relaxivities of albumin bound and non albumin bound contrast agents: From theory to practice
|
Port, Marc |
|
2005 |
12 |
5S |
p. S79-S80 2 p. |
artikel |
36 |
Iosimenol: The Second Generation of Nonionic Dimers
|
Sovak, Milos |
|
2005 |
12 |
5S |
p. S52-S53 2 p. |
artikel |
37 |
Low-Density Oral Contrast Agent for Abdominal Helical CT
|
Collares, Felipe Birchal |
|
2005 |
12 |
5S |
p. S84-S85 2 p. |
artikel |
38 |
Magnetic Resonance: Contrast enhancement of short T2 tissues in the musculoskeletal system
|
Bydder, Graeme M. |
|
2005 |
12 |
5S |
p. S44-S45 2 p. |
artikel |
39 |
Magnevist ® (gadopentetate dimeglumine) does not interfere with the determination of calcium levels in plasma or serum
|
Löwe, Andrea |
|
2005 |
12 |
5S |
p. S47-S48 2 p. |
artikel |
40 |
Microbubble Kinetics in Indirect Ultrasound Lymphography
|
Kono, Yuko |
|
2005 |
12 |
5S |
p. S50-S51 2 p. |
artikel |
41 |
Molecular Imaging of Human Thrombus with Computed Tomography
|
Winter, Patrick M. |
|
2005 |
12 |
5S |
p. S9-S13 5 p. |
artikel |
42 |
Molecular Imaging of αvβ3-Integrin: An Opportune Biochemical Signature For Oncologic and Cardiovascular Diseases
|
Winter, Patrick M. |
|
2005 |
12 |
5S |
p. S43- 1 p. |
artikel |
43 |
Monitoring the Acute Microvascular Effects of Anti-Inflammatory Steroid Treatment in a Rat Arthritis Model Using Macromolecular Contrast-Enhanced Magnetic Resonance Imaging
|
Lucidi, Vincenzo |
|
2005 |
12 |
5S |
p. S78-S79 2 p. |
artikel |
44 |
MR-Angiography of the Coronary Arteries with the New Iron Oxide Blood-Pool Contrast Medium VSOP-C184: Results of a Phase Ib Clinical Trial
|
Taupitz, Matthias |
|
2005 |
12 |
5S |
p. S61-S62 2 p. |
artikel |
45 |
MR Imaging-Guided Endovascular Procedures: Are Contrast Agents Necessary to Improve Passive Tracking Techniques?
|
Wacker, Frank K. |
|
2005 |
12 |
5S |
p. S63-S64 2 p. |
artikel |
46 |
MRI of Liver Tumors: Comparison of the Iron-Oxide-Based Blood Pool Contrast Medium VSOP-C184 with the Liver-Specific SPIO Resovist and the Low-Molecular Substance Multihance in an Animal Model
|
Schnorr, Jörg |
|
2005 |
12 |
5S |
p. S56- 1 p. |
artikel |
47 |
Multidetector CT in abdominal imaging: Optimization of iodine concentration for the diagnosis of abdominal tumors. Use of high concentration contrast media
|
Hammerstingl, Renate M. |
|
2005 |
12 |
5S |
p. S84- 1 p. |
artikel |
48 |
Non-invasive quantitative assessment of angiogenesis with contrast enhanced functional ultrasound imaging in a non-tumor animal model
|
Lucidarme, Olivier |
|
2005 |
12 |
5S |
p. S68-S69 2 p. |
artikel |
49 |
Optical imaging and Quantitation
|
Hall, David J. |
|
2005 |
12 |
5S |
p. S72-S73 2 p. |
artikel |
50 |
Optical imaging of protease activity in rheumatoid arthritis
|
Mahmood, Umar |
|
2005 |
12 |
5S |
p. S75-S76 2 p. |
artikel |
51 |
Optimized Labeling of Hematopoietic Progenitor Cells derived from umbilical cord blood or peripheral blood with iron oxide contrast agents for in vivo depiction with MR imaging at 1.5 Tesla
|
Daldrup-Link, Heike E. |
|
2005 |
12 |
5S |
p. S38-S39 2 p. |
artikel |
52 |
Oral manganese for liver and bile imaging
|
Thomsen, Henrik S. |
|
2005 |
12 |
5S |
p. S21-S23 3 p. |
artikel |
53 |
Perfusion CT of Rectal Cancer: Assessing Tumor Vascularity (Angiogenesis) and Response to Radiotherapy - Initial Observations
|
Sahani, Dushyant V. |
|
2005 |
12 |
5S |
p. S85- 1 p. |
artikel |
54 |
Plasma Volume and Permeability Coefficient measurements in the C6 glioma model using Synchrotron Radiation CT coupled to injection of P743, Xenetix and Iomeron
|
Duc, G. Le |
|
2005 |
12 |
5S |
p. S57-S58 2 p. |
artikel |
55 |
Radiation dose enhancement with an iodinated contrast agent
|
Joubert, A. |
|
2005 |
12 |
5S |
p. S58- 1 p. |
artikel |
56 |
Radioiodinated NM404-a Universal Tumor Imaging Agent?
|
Weichert, J.P. |
|
2005 |
12 |
5S |
p. S58-S59 2 p. |
artikel |
57 |
Real-Time Tumor Labeling and Biodistribution Imaging Using Folate-Receptor (FR) Targeted Imaging Agents
|
Benaron, David A. |
|
2005 |
12 |
5S |
p. S75- 1 p. |
artikel |
58 |
Research on Necrosis Avid Contrast Agents: Further Expansion of Scope
|
Ni, Y. |
|
2005 |
12 |
5S |
p. S55- 1 p. |
artikel |
59 |
Retention of Gadolinium in Human Bone Tissue
|
Gibby, W. |
|
2005 |
12 |
5S |
p. S47- 1 p. |
artikel |
60 |
Selecting vectors to image apoptosis by phage display technique
|
Laumonier, Catherine |
|
2005 |
12 |
5S |
p. S42-S43 2 p. |
artikel |
61 |
Structural and Functional Characterization of Chronic Obstructive Lung Disease and Emphysema Using 3He- MRI: Comparison with CT and Pulmonary Function Tests
|
Kauczor, Hans-Ulrich |
|
2005 |
12 |
5S |
p. S69-S70 2 p. |
artikel |
62 |
Subchronic Toxicity of the Gadolinium Chelates
|
Runge, Val M. |
|
2005 |
12 |
5S |
p. S6-S9 4 p. |
artikel |
63 |
Table of contents
|
|
|
2005 |
12 |
5S |
p. A3-A8 nvt p. |
artikel |
64 |
Technical and Practical Considerations for Permeability Modeling of Dynamic Contrast Enhanced MRI
|
Roberts, Tim |
|
2005 |
12 |
5S |
p. S34-S37 4 p. |
artikel |
65 |
The Radiosynthesis of [2-18F] Fluorodeoxyglucose Using a Resin Bound Precursor
|
Bouvet, D. |
|
2005 |
12 |
5S |
p. S59-S60 2 p. |
artikel |
66 |
“This Contrast Medium Will not Burn at All.” Unintended Nocebo Effects and Considerations for the Design of Clinical Trials
|
Lang, Elvira V. |
|
2005 |
12 |
5S |
p. S54-S55 2 p. |
artikel |
67 |
Thromboembolic disease: Assessment with whole body MR venography
|
Ruehm, Stefan G. |
|
2005 |
12 |
5S |
p. S63- 1 p. |
artikel |
68 |
Toward the Goal of Signal Quantification in Contrast-Enhanced Optical Imaging
|
Brasch, Robert |
|
2005 |
12 |
5S |
p. S73-S74 2 p. |
artikel |
69 |
Transition Metal Cluster and Polygadolinium Compounds as a New Paradigm For High Attenuation and/or Relaxivity in Contrast Media Design: Crashing The Molecular r1 = 100 Barrier
|
Messerle, Louis |
|
2005 |
12 |
5S |
p. S46-S47 2 p. |
artikel |
70 |
Untitled
|
Su, Henry S. |
|
2005 |
12 |
5S |
p. S77- 1 p. |
artikel |
71 |
Use Of Contrast-Enhanced Ultrasonography To Monitor Local Ablative Treatment Of Liver Cancer
|
Spinazzi, Alberto |
|
2005 |
12 |
5S |
p. S66-S67 2 p. |
artikel |
72 |
Validation of Ultrasound Contrast Destruction Imaging for Flow Quantification
|
Lucidarme, Olivier |
|
2005 |
12 |
5S |
p. S68- 1 p. |
artikel |
73 |
Value Of USPIO (Sinerem®) Enhanced MRI in The Assessment of Axillary Lymph Nodes in Breast Cancer
|
Helbich, T.H. |
|
2005 |
12 |
5S |
p. S52- 1 p. |
artikel |
74 |
Virtual MicroCT Angiography with BP20 in Live Mice
|
Weichert, J.P. |
|
2005 |
12 |
5S |
p. S48-S49 2 p. |
artikel |